INVATECH FDA Approval ANDA 210215

ANDA 210215

INVATECH

FDA Drug Application

Application #210215

Application Sponsors

ANDA 210215INVATECH

Marketing Status

Prescription001

Application Products

001TABLET;ORAL100MG0AMANTADINE HYDROCHLORIDEAMANTADINE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2020-03-10STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB

CDER Filings

NOVELGENIX THERAPS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 210215
            [companyName] => NOVELGENIX THERAPS
            [docInserts] => ["",""]
            [products] => [{"drugName":"AMANTADINE HYDROCHLORIDE","activeIngredients":"AMANTADINE HYDROCHLORIDE","strength":"100MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"03\/10\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-03-10
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.